Educational illustration · Read the evidence and limitations below.
Evidence in perspective
Isolated follicles and cultured dermal cells allow mechanistic experiments, but cannot measure a patient’s hair density, cosmetic satisfaction or long-term scalp safety. Copper-peptide identities must stay separate.
About this assessment
Existing source snapshot critically reassessed.
Based on the selected source scope described in this profile, often an indexed abstract. Full methods and clinician sign-off remain pending; no systematic-review claim.
A targeted source review, not a complete clinical monograph. Product stability, long-term safety, interactions and jurisdiction-specific authorization require further verification. Research findings do not validate commercial vials.
How it works
Pyo and colleagues observed follicle elongation and dermal papilla cell proliferation under laboratory exposure to AHK-Cu.
Pyo and colleagues observed follicle elongation and dermal papilla cell proliferation under laboratory exposure to AHK-Cu.
Ex vivo follicles / in vitro cells; not an injectable or topical clinical product.
AHK-Cu is an alanine–histidine–lysine copper complex studied in isolated human hair follicles and cultured dermal papilla cells. That is laboratory research, not evidence that a scalp product reverses hair loss in patients.
Ex vivo follicles / in vitro cells; not an injectable or topical clinical product.